InvestorsHub Logo
Followers 134
Posts 3737
Boards Moderated 0
Alias Born 01/28/2006

Re: Lemoncat post# 354740

Thursday, 04/08/2021 9:14:55 AM

Thursday, April 08, 2021 9:14:55 AM

Post# of 402749
Aarthi Narayanan1 was the lead researcher and author for the first Brilacidin publication in, Viruses.

Dr Narayanan should be well known to her peers as she has dozens of publications related to viral research including several for Covid19 and Alpha viruses. My guess is she would be invited to make the Brilacidin presentation at the conference.

https://scholar.google.com/scholar?start=30&q=%22Aarthi+Narayanan%22&hl=en&as_sdt=0,18

Your negativity is unwarranted. The presentation will publicize Brilacidin to some of the leading virologists in the world at a time where viral research has been the focus of the scientific, government and medical communities.

The press will cover this conference with great interest for any reports of possible therapeutic treatments for Covid19.

The presentation is an acknowledgement of Brilacidin's activity against Covid19 and it is a big deal.

GLTA,

Farrell
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News